Scientists Jointly Urge FDA to Evaluate T-Cell Response in Review of COVID-19 Vaccines
More than 60 scientists have signed a letter to the U.S. Food and Drug Administration (FDA), requesting that in addition to measuring antibodies after vaccination, the agency should also focus on measuring T-cell responses to help make more accurate, long-term assessments of vaccine effectiveness and to make effective preventive decisions before new mutations of SARS-CoV-2 occur.
It's free! Log in now to read
LATEST
Neurosurgery Now: NVIDIA’s Holoscan AI Brings Real-Time 3D Vision to Enhance Surgical Precision at 2025 GTC
2025-03-18
NVIDIA GTC 2025: BioMap’s xTrimo — The AI Model That’s Changing Biotech and Drug Discovery
2025-03-18